Kevin Judice is the founder of DiCE Molecules. DiCE Molecules has raised $50M in total funding. Latest round: Seed. Backed by Sanofi.
J. Kevin Judice is the co-founder and Chief Executive Officer of DiCE Molecules, a biotechnology company founded in 2014. DiCE Molecules develops oral small-molecule therapies for immunology using DNA-directed chemical evolution, aiming to design innovative oral alternatives to injectable biologic medicines for patients with serious medical conditions. He is a Genentech veteran and longtime biotech entrepreneur based on the West Coast.
Full founder directory · Investor directory · Company funding database · Fundraising library